Entities / Company
Corbus Pharmaceuticals.
company in Norwood, United States
- Reports this week
- 1
- Active events
- 1
- Connections
- 21
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
Gone quiet
No new reports in 90+ days-
Corbus Pharmaceuticals and Vyne Therapeutics Inc. are facing competitor comparisons based on their financial metrics.Some support1 report
-
Corbus Pharmaceuticals listed on the stock exchange and received rating reports from various firms.Some support2 reports
-
Charles Schoch, who holds an MBA and MSA from Northeastern University, served as Corporate Controller at Corbus Pharmaceuticals and was appointed CFO of Candel Therapeutics.Speculative1 report
-
Corbus Pharmaceuticals is headquartered in Norwood, Massachusetts.Speculative1 report
-
Corbus Pharmaceuticals presented clinical data at the ESMO Congress on July 30, 2025, held in Berlin, following trials conducted in the United States.Some support1 report
-
Yuval Cohen was appointed CEO of Corbus Pharmaceuticals.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Corbus Pharmaceuticals this week
News at the entities that move Corbus Pharmaceuticals most-
Nasdaq StructuralOpenWorld, led by CEO Matthew Shaw, filed reports with the SEC and is listed on the Nasdaq exchange.Moves Corbus Pharmaceuticals
-
MarketBeat Mentioned togetherMarketBeat reports TSM average rating while Susquehanna raises its price target on TSM stock.Moves Corbus Pharmaceuticals
Connections
The 5 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Yuval Cohen Structural
Yuval Cohen serves as the Chief Executive Officer of Corbus Pharmaceuticals.
-
Nasdaq Structural
Corbus Pharmaceuticals is listed on the Nasdaq stock exchange, establishing a structural dependence on the exchange's infrastructure.
-
MarketBeat Mentioned together
MarketBeat reports on Corbus Pharmaceuticals stock.
-
Norwood Shared context
Corbus Pharmaceuticals is headquartered in Norwood, Massachusetts.
-
Pale Fire Capital Transactional
Pale Fire Capital executed a specific investment action by lifting its position in Corbus Pharmaceuticals stock.
History
Events by the month they beganNovember 2026
1 eventSeptember 2026
1 eventAugust 2026
1 eventShow 1 earlier month
June 2026
6 events- Corbus Pharmaceuticals and Vyne Therapeutics Inc. are facing competitor comparisons based on their financial metrics.
- Corbus Pharmaceuticals listed on the stock exchange and received rating reports from various firms.
- Charles Schoch, who holds an MBA and MSA from Northeastern University, served as Corporate Controller at Corbus Pharmaceuticals and was appointed CFO of Candel Therapeutics.
- Corbus Pharmaceuticals is headquartered in Norwood, Massachusetts.
- Corbus Pharmaceuticals presented clinical data at the ESMO Congress on July 30, 2025, held in Berlin, following trials conducted in the United States.
- Yuval Cohen was appointed CEO of Corbus Pharmaceuticals.